N/A
Manufactured by Accuria, LLC
5,771 FDA adverse event reports analyzed
Last updated: 2026-04-15
TETRACYCLINE HYDROCHLORIDE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Accuria, LLC. The most commonly reported adverse reactions for TETRACYCLINE HYDROCHLORIDE include OFF LABEL USE, DRUG HYPERSENSITIVITY, HYPERSENSITIVITY, PNEUMONIA, INTENTIONAL PRODUCT USE ISSUE. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for TETRACYCLINE HYDROCHLORIDE.
Out of 740 classified reports for TETRACYCLINE HYDROCHLORIDE:
The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.
This profile reflects 5,771 FDA FAERS reports that mention TETRACYCLINE HYDROCHLORIDE. Reporting is voluntary and does not prove that the drug caused any listed event.
Frequently reported terms in FAERS include OFF LABEL USE, DRUG HYPERSENSITIVITY, HYPERSENSITIVITY, PNEUMONIA, INTENTIONAL PRODUCT USE ISSUE, PAIN IN EXTREMITY. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.
Labeling and FAERS entries often list Accuria, LLC in connection with TETRACYCLINE HYDROCHLORIDE. Always verify the specific product and NDC with your pharmacist.